Rebecca S Lash1, Janice F Bell, Sarah C Reed, Hermine Poghosyan, James Rodgers, Katherine K Kim, Richard J Bold, Jill G Joseph. 1. Author Affiliations: Collaborative Cancer Care Research Group (3CRG), Betty Irene Moore School of Nursing, University of California, Davis, Sacramento (Drs Lash, Bell, Kim, Bold, and Joseph; Ms Reed; and Mr Rodgers); Department of Nursing Research and Education, UCLA Health (Dr Lash); and College of Nursing and Health Sciences University of Massachusetts, Boston (Dr Poghosyan).
Abstract
BACKGROUND: Recent reports call for reductions in costly and potentially avoidable services such as emergency department (ED) visits. Providing high-quality and safe care for oncology patients remains challenging for ED providers given the diversity of patients seeking care and the unpredictable clinical environment. While ED use by oncology patients is appropriate for acute health concerns, some ED visits may be preventable with well-coordinated care and adequate symptom management. OBJECTIVE: The aim of this study was to summarize available evidence regarding the incidence, predictors of, and reasons for ED visits among oncology patients. METHODS: Keyword/MeSH term searches were conducted using 4 online databases. Inclusion criteria were publication date between April 1, 2003, and December 5, 2014; sample size of 50 or more; and report of the incidence or predictors of ED use among oncology patients. RESULTS: The 15 studies that met criteria varied in study aim, design, and time frames for calculating ED utilization rates. The incidence of ED visits among oncology patients ranged from 1% to 83%. The 30-day standardized visit rate incidence ranged from 1% to 12%. Collectively, the studies lack population-based estimates for all cancers combined. CONCLUSIONS: The studies included in this review suggest that rates of ED use among cancer patients exceed those of the general population. However, the extent of ED use by oncology patients and the reasons for ED visits remain understudied. IMPLICATIONS FOR PRACTICE: Nurses are involved in the treatment of cancer, patient education, and symptom management. Nurses are well positioned to develop patient-centered treatment and care coordination plans to improve quality of care and reduce ED visits.
BACKGROUND: Recent reports call for reductions in costly and potentially avoidable services such as emergency department (ED) visits. Providing high-quality and safe care for oncology patients remains challenging for ED providers given the diversity of patients seeking care and the unpredictable clinical environment. While ED use by oncology patients is appropriate for acute health concerns, some ED visits may be preventable with well-coordinated care and adequate symptom management. OBJECTIVE: The aim of this study was to summarize available evidence regarding the incidence, predictors of, and reasons for ED visits among oncology patients. METHODS: Keyword/MeSH term searches were conducted using 4 online databases. Inclusion criteria were publication date between April 1, 2003, and December 5, 2014; sample size of 50 or more; and report of the incidence or predictors of ED use among oncology patients. RESULTS: The 15 studies that met criteria varied in study aim, design, and time frames for calculating ED utilization rates. The incidence of ED visits among oncology patients ranged from 1% to 83%. The 30-day standardized visit rate incidence ranged from 1% to 12%. Collectively, the studies lack population-based estimates for all cancers combined. CONCLUSIONS: The studies included in this review suggest that rates of ED use among cancerpatients exceed those of the general population. However, the extent of ED use by oncology patients and the reasons for ED visits remain understudied. IMPLICATIONS FOR PRACTICE: Nurses are involved in the treatment of cancer, patient education, and symptom management. Nurses are well positioned to develop patient-centered treatment and care coordination plans to improve quality of care and reduce ED visits.
Authors: Hanna K Sanoff; William R Carpenter; Janet Freburger; Ling Li; Kun Chen; Leah L Zullig; Richard M Goldberg; Maria J Schymura; Deborah Schrag Journal: Cancer Date: 2012-01-31 Impact factor: 6.860
Authors: Christopher J Coyne; Cielito C Reyes-Gibby; Danielle D Durham; Beau Abar; David Adler; Aveh Bastani; Steven L Bernstein; Christopher W Baugh; Jason J Bischof; Corita R Grudzen; Daniel J Henning; Matthew F Hudson; Adam Klotz; Gary H Lyman; Troy E Madsen; Daniel J Pallin; Juan Felipe Rico; Richard J Ryan; Nathan I Shapiro; Robert Swor; Charles R Thomas; Arvind Venkat; Jason Wilson; Sai-Ching Jim Yeung; Jeffrey M Caterino Journal: Support Care Cancer Date: 2021-01-22 Impact factor: 3.603
Authors: Deniz Can Guven; Furkan Ceylan; Ibrahim Yahya Cakir; Engin Cesmeci; Basak Sayinalp; Berkay Yesilyurt; Gurkan Guner; Hasan Cagri Yildirim; Oktay Halit Aktepe; Zafer Arik; Alev Turker; Omer Dizdar Journal: Support Care Cancer Date: 2021-01-06 Impact factor: 3.603
Authors: Frank Daniel Martos-Benítez; Andrés Soto-García; Anarelys Gutiérrez-Noyola Journal: J Cancer Res Clin Oncol Date: 2018-01-23 Impact factor: 4.553
Authors: Igor Stukalin; Newaz Shubidito Ahmed; Adam M Fundytus; Alexander S Qian; Stephanie Coward; Gilaad G Kaplan; Robert J Hilsden; Kelly W Burak; Jeffrey K Lee; Siddharth Singh; Christopher Ma Journal: Gastroenterology Date: 2021-12-16 Impact factor: 22.682
Authors: Nayan Lamba; Paul J Catalano; Colleen Whitehouse; Kate L Martin; Mallika L Mendu; Daphne A Haas-Kogan; Patrick Y Wen; Ayal A Aizer Journal: Neurooncol Pract Date: 2021-05-21
Authors: Joann Hsu; John P Donnelly; Justin Xavier Moore; Karen Meneses; Grant Williams; Henry E Wang Journal: Am J Emerg Med Date: 2018-03-13 Impact factor: 2.469
Authors: Lilla Prenek; Klára Csupor; Péter Beszterczán; Krisztina Boros; Erika Kardos; András Vorobcsuk; Miklós Egyed; Ádám Kellner; Péter Rajnics; Csaba Varga Journal: Int J Emerg Med Date: 2021-05-07
Authors: Alex Fauer; Lauren P Wallner; Matthew A Davis; Sung Won Choi; Christopher R Friese Journal: J Geriatr Oncol Date: 2020-09-20 Impact factor: 3.599